abstract |
The present invention relates to a steroid hormone dependent disease or disorder useful in therapy, preferably a 17β-hydroxysteroid dehydrogenase (17β-HSD) enzyme, such as a 17β-HSD type 1, type 2 or type 3 enzyme. It relates to compounds for use in the treatment and / or prevention of steroid hormone dependent diseases or disorders in need of inhibition. |